What is the significance of a 31ml ovary with 20 antral follicles in a female of reproductive age with no significant medical history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ovarian Findings Consistent with Polycystic Ovarian Morphology

Your findings of a 31ml ovary with 20 antral follicles meet the diagnostic threshold for polycystic ovarian morphology (PCOM) and require evaluation for polycystic ovary syndrome (PCOS). 1

Interpretation of Your Ultrasound Findings

Ovarian Volume Assessment

  • Your ovarian volume of 31ml (31 cm³) significantly exceeds the diagnostic threshold of ≥10ml for PCOM 1
  • This volume is approximately 3 times larger than the PCOM cutoff, making this a definitive finding 1
  • Normal ovarian volume in reproductive-age women ranges from 6.5-8.4 cm³, so your finding represents marked enlargement 2

Antral Follicle Count Assessment

  • Your count of 20 antral follicles is at the exact threshold for PCOM when using modern ultrasound technology (≥8 MHz transvaginal transducer) 1
  • The updated 2014 Androgen Excess and PCOS Society criteria require ≥20 follicles measuring 2-9mm in diameter in at least one ovary 1
  • This represents a revision from older criteria that used ≥12 follicles, reflecting improved ultrasound resolution 1

Technical Considerations

  • Confirm your ultrasound was performed with a transvaginal transducer with frequency bandwidth ≥8 MHz, as this is required for accurate follicle detection and the ≥20 follicle threshold 1
  • Ensure no corpus luteum, cysts, or dominant follicles ≥10mm were present, as these would invalidate the PCOM diagnosis 1
  • The scan should ideally be performed in the early follicular phase (cycle days 2-5), though PCOM can be assessed throughout the cycle 3

Clinical Significance and Next Steps

PCOS Evaluation Required

You require clinical and biochemical evaluation for PCOS, as ultrasound findings alone cannot diagnose the syndrome. 1

The diagnosis of PCOS requires two of three Rotterdam criteria:

  • Oligo-ovulation or anovulation (irregular menstrual cycles)
  • Clinical or biochemical hyperandrogenism (hirsutism, acne, elevated testosterone)
  • Polycystic ovarian morphology on ultrasound 1

Recommended Laboratory Testing

  • Anti-Müllerian hormone (AMH): Expected to be elevated in PCOS, though not yet validated as a standalone diagnostic test 1
  • Total and free testosterone: To assess for biochemical hyperandrogenism 4
  • FSH and LH on cycle day 2-3: LH:FSH ratio >2:1 supports PCOS 4
  • TSH: To exclude thyroid dysfunction mimicking PCOS 4
  • Fasting glucose and insulin: To screen for insulin resistance and metabolic syndrome 4

Important Clinical Context

If you have regular menstrual cycles (21-35 days) AND no signs of hyperandrogenism (no excess hair growth, acne, or male-pattern hair loss), you have isolated PCOM without PCOS. 1

  • Isolated PCOM occurs in approximately 20-30% of reproductive-age women and does not require PCOS treatment 1
  • However, these women may have higher ovarian response to fertility medications if pursuing assisted reproduction 5

If you have irregular cycles OR hyperandrogenism, you meet diagnostic criteria for PCOS and require metabolic screening and treatment. 1

Fertility Implications

Ovarian Reserve Assessment

  • Your antral follicle count of 20 indicates excellent ovarian reserve, far exceeding the threshold for diminished reserve (<5 follicles) 1, 3
  • This suggests robust fertility potential from a quantitative standpoint 3, 6

Ovulation Status

  • PCOM is associated with ovulatory dysfunction in approximately 70% of PCOS cases 1
  • Confirm ovulation with midluteal progesterone (cycle day 21) to determine if ovulatory dysfunction is present 4
  • If anovulatory with fertility goals, first-line treatment is letrozole or clomiphene citrate 1

Assisted Reproduction Considerations

  • Women with PCOM are at increased risk of ovarian hyperstimulation syndrome (OHSS) during fertility treatment 5
  • Lower gonadotropin doses and careful monitoring are required if pursuing IVF 5

Common Pitfalls to Avoid

  • Do not assume PCOS diagnosis based on ultrasound alone—clinical and biochemical criteria are mandatory 1
  • Do not dismiss PCOM as insignificant if you have menstrual irregularity or signs of hyperandrogenism 1
  • Do not use AMH as a standalone diagnostic test for PCOS, as thresholds are not yet validated across populations 1
  • Do not confuse PCOM with diminished ovarian reserve—these are opposite ends of the spectrum 3, 7

Asymmetry Consideration

  • The right ovary typically contains 1-2 more follicles than the left ovary in normal women 8
  • If only one ovary shows PCOM findings, this still meets diagnostic criteria, as the threshold applies to "at least one ovary" 1
  • Significant asymmetry (>10ml volume difference) should prompt evaluation for unilateral pathology 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Assessment of Ovarian Reserve and Fertility Potential

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Female Fertility Assessment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Are all antral follicles the same? Size of antral follicles as a key predictor for response to controlled ovarian stimulation.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2022

Guideline

Ovarian Asymmetry and Diminished Ovarian Reserve

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lateralization of ovarian follicles.

Gynecologic and obstetric investigation, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.